Submission Details
| 510(k) Number | K142800 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 29, 2014 |
| Decision Date | December 11, 2014 |
| Days to Decision | 73 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K142800 is an FDA 510(k) clearance for the Rapid Single/Multi-drug Test Cup and Rapid Single/Multi-drug Test Dipcard, a Enzyme Immunoassay, Amphetamine (Class II — Special Controls, product code DKZ), submitted by Co-Innovation Biotech Co., Ltd. (Guangzhou, CN). The FDA issued a Cleared decision on December 11, 2014, 73 days after receiving the submission on September 29, 2014. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K142800 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 29, 2014 |
| Decision Date | December 11, 2014 |
| Days to Decision | 73 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3100 |